T. Rowe Price Associates’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-508,872
Closed -$58.7M 2886
2020
Q4
$58.7M Buy
508,872
+33,356
+7% +$3.85M 0.01% 902
2020
Q3
$46.3M Sell
475,516
-105,180
-18% -$10.2M 0.01% 897
2020
Q2
$71.3M Buy
580,696
+86,085
+17% +$10.6M 0.01% 732
2020
Q1
$43.3M Sell
494,611
-225,289
-31% -$19.7M 0.01% 829
2019
Q4
$75.3M Buy
719,900
+290,939
+68% +$30.4M 0.01% 762
2019
Q3
$49.3M Sell
428,961
-16,597
-4% -$1.91M 0.01% 877
2019
Q2
$76.8M Sell
445,558
-27,550
-6% -$4.75M 0.01% 721
2019
Q1
$79.8M Sell
473,108
-28,469
-6% -$4.8M 0.01% 702
2018
Q4
$48.8M Sell
501,577
-249,139
-33% -$24.3M 0.01% 831
2018
Q3
$130M Sell
750,716
-113,133
-13% -$19.5M 0.02% 602
2018
Q2
$121M Buy
863,849
+184,268
+27% +$25.7M 0.02% 610
2018
Q1
$76.6M Sell
679,581
-317,419
-32% -$35.8M 0.01% 715
2017
Q4
$132M Buy
997,000
+36,874
+4% +$4.87M 0.02% 561
2017
Q3
$97.4M Buy
960,126
+146,824
+18% +$14.9M 0.02% 631
2017
Q2
$81.5M Buy
813,302
+79,618
+11% +$7.98M 0.01% 665
2017
Q1
$88.7M Buy
733,684
+266,790
+57% +$32.3M 0.02% 628
2016
Q4
$52.2M Sell
466,894
-74,720
-14% -$8.35M 0.01% 795
2016
Q3
$71.9M Buy
541,614
+379,440
+234% +$50.4M 0.01% 679
2016
Q2
$14.9M Buy
+162,174
New +$14.9M ﹤0.01% 1189
2014
Q3
Sell
-145,724
Closed -$15.6M 2577
2014
Q2
$15.6M Sell
145,724
-153,115
-51% -$16.4M ﹤0.01% 1187
2014
Q1
$17.7M Buy
298,839
+153,709
+106% +$9.13M ﹤0.01% 1147
2013
Q4
$6.03M Hold
145,130
﹤0.01% 1401
2013
Q3
$2.52M Hold
145,130
﹤0.01% 1509
2013
Q2
$1.26M Buy
+145,130
New +$1.26M ﹤0.01% 1602